Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05659524 · ClinicalTrials.gov registry record · NA
Nasal Outcomes Using Saline Irrigations After Endonasal Pituitary Surgery
A NA study of Pituitary Tumor, sponsored by Lori Wood.
- Recruiting
- Registry status
- NA
- Development phase
- 140
- Enrollment target
- 2
- Study locations
NCT05659524: Recruiting NA study of Pituitary Tumor, sponsored by Lori Wood.
NCT05659524 is a NA study of Pituitary Tumor that is actively recruiting participants, run by Lori Wood. The registered enrollment target is 140 participants, below the 396-participant average among 5 other Pituitary Tumor trials with a reported enrollment target (65% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05659524, a NA study of Pituitary Tumor, is actively recruiting participants, sponsored by Lori Wood.
- RECRUITING
- Registry status
- NA
- Development phase
- 140 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a prospective, single-blinded, multicenter study evaluating the benefit of sinonasal irrigations following endoscopic pituitary surgery. The goal of this study is to create practice changing guidelines with objective data highlighting the importance of irrigations on postoperative outcomes for pituitary surgery.
Primary Outcome
Difference in mean sinonasal quality of life between groups as determined by patient reported Sino-nasal Outcome Test (SNOT-22) scores at 4 weeks. SNOT-22 scoring can be completed during a clinic visit or by phone interview. It is critical that the follow-up times are standardized because symptoms improve with time. A reduction in SNOT-22 composite score is indicative of improvement in symptoms.
Conditions Studied
Interventions
- OTHER Nasal saline irrigation
Study Locations (2)
Arizona
- Barrow Neurological Institute at St. Joseph's Hospital and Medical Center - Phoenix
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2020-12-18 |
| Est. Completion | 2029-12-31 |
| Phase | NA |
What NCT05659524 shows while recruiting
NCT05659524 is an interventional study that assigns participants to a tested intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap, below the 396-participant average among 5 other Pituitary Tumor trials with a reported enrollment target (65% lower).
The record links to 1 condition, with Pituitary Tumor appearing as the primary indexed condition, and to 1 intervention - of which Nasal saline irrigation is the first listed.
NCT05659524 reports a single indexed study location in Arizona, Ohio.
Frequently Asked Questions
What is clinical trial NCT05659524 about?
NCT05659524 is a clinical study titled "Nasal Outcomes Using Saline Irrigations After Endonasal Pituitary Surgery". This is a prospective, single-blinded, multicenter study evaluating the benefit of sinonasal irrigations following endoscopic pituitary surgery. The goal of this study is to create practice changing guidelines with objective data highlighting the importance of irrigations on postoperative outcomes f...
What is the current status of trial NCT05659524?
This trial is currently recruiting. It is a NA study. The enrollment target is 140 participants. The study started on 2020-12-18. Estimated completion is 2029-12-31.
What conditions does trial NCT05659524 study?
This clinical trial studies the following conditions: Pituitary Tumor.
What interventions are being tested in trial NCT05659524?
The interventions under investigation include: Nasal saline irrigation (OTHER).
Who is sponsoring clinical trial NCT05659524?
This trial is sponsored by Lori Wood, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05659524 being conducted?
This trial has 2 study locations across Arizona, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pituitary Tumor
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluation of the CONVIVO System
RECRUITING · NA
-
Pituitary Tumor Surveillance: Pathogenic Correlation
RECRUITING
-
Long-Term Longitudinal QoL in Patients Undergoing EEA
RECRUITING
-
Nivolumab and Ipilimumab in People With Aggressive Pituitary Tumors
ACTIVE NOT RECRUITING · Phase 2
-
Prospective Study of Clinically Nonfunctioning Pituitary Adenomas
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI